Early research (Phase 1)Study completedNCT01563068
What this trial is testing
Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis
Who this might be right for
Psoriasis
Mayne Pharma International Pty Ltd 18